Epidemiologic observations guiding clinical application of a urinary peptidomic marker of diastolic left ventricular dysfunction

Zhen-Yu Zhang, Esther Nkuipou-Kenfack, Wen-Yi Yang, Fang-Fei Wei, Nicholas Cauwenberghs, Lutgarde Thijs, Qi-Fang Huang, Ying-Mei Feng, Joost P. Schanstra, Tatiana Kuznetsova, Jens-Uwe Voigt, Peter Verhamme, Harald Mischak, Jan A. Staessen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)438-447.e4
Number of pages10
JournalJournal of the American Society of Hypertension
Volume12
Issue number6
DOIs
Publication statusPublished - 1 Jun 2018

Keywords

  • Diastolic left ventricular function
  • population science
  • screening
  • urinary proteomics
  • PRESERVED EJECTION FRACTION
  • AMBULATORY BLOOD-PRESSURE
  • GENERAL-POPULATION
  • PROTEOME ANALYSIS
  • HEART-FAILURE
  • RENAL-FUNCTION
  • DISEASE
  • PREVALENCE
  • GUIDELINES
  • DISCOVERY
  • STANDARDS

Cite this

Zhang, Z-Y., Nkuipou-Kenfack, E., Yang, W-Y., Wei, F-F., Cauwenberghs, N., Thijs, L., Huang, Q-F., Feng, Y-M., Schanstra, J. P., Kuznetsova, T., Voigt, J-U., Verhamme, P., Mischak, H., & Staessen, J. A. (2018). Epidemiologic observations guiding clinical application of a urinary peptidomic marker of diastolic left ventricular dysfunction. Journal of the American Society of Hypertension, 12(6), 438-447.e4. https://doi.org/10.1016/j.jash.2018.03.007